ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2026, Vol. 35 ›› Issue (3): 292-296.DOI: 10.3969/j.issn.1006-298X.2026.03.018

• 病例报告 • 上一篇    下一篇

肾移植后 2,8 - 二羟基腺嘌呤结晶性肾病

  

  • 出版日期:2026-06-29 发布日期:2026-07-02

2,8-Dihydroxyadenine crystalline nephropathy in renal allograft

  • Online:2026-06-29 Published:2026-07-02

摘要: 40 岁男性患者,首次就诊时即为慢性肾脏病 5 期,伴轻度蛋白尿、右肾多发钙化及输尿管结石,并有肾结石家族史。肾移植术后出现移植肾功能延迟恢复,移植肾病理显示肾小管内棕褐色、具折光性的结晶;尿沉渣镜检显示黄棕色球状结晶,偏振光下呈典型 “马耳他十字” 外观。经基因检测证实为 APRT 基因复合杂合突变,最终诊断为腺嘌呤磷酸核糖基转移酶缺乏症引起的 2,8 - 二羟基腺嘌呤结晶性肾病。经非布司他治疗后血清肌酐进一步下降。

关键词: 2,8 - 二羟基腺嘌呤, 腺嘌呤磷酸核糖基转移酶缺乏症, 肾结石, 肾移植

Abstract: A 40-year-old man presented with chronic kidney disease stage 5 at initial presentation, accompanied by mild proteinuria, right renal multiple calcifications, and ureteral stones, along with a positive family history of nephrolithiasis. Following renal transplantation, delayed graft function occurred. Allograft biopsy showed brownish, birefringent crystals in the tubules. Urine sediment microscopy showed yellowish-brown spherical crystals exhibiting a typical “Maltese cross” appearance under polarized light. Genetic testing confirmed a compound heterozygous mutation in the APRT gene. The final diagnosis was 2,8-dihydroxyadenine (2,8-DHA) crystalline nephropathy due to adenine phosphoribosyltransferase deficiency. Following treatment with febuxostat, serum creatinine further decreased.

Key words: 2,8-dihydroxyadenine, adenine phosphoribosyltransferasedeficiency, nephrolithiasis, kidney transplantation

中图分类号: